With tens of millions of people at risk of falling into extreme poverty & malnutrition because of #COVID19 pandemic, global solidarity & support are needed more to than ever to help those in need.
"6 months ago, WHO launched the Solidarity Trial to evaluate the effectiveness of 4 drugs for the #COVID19 treatment.
The Solidarity Trial is the 🌍’s largest randomized controlled trial of COVID-19 therapeutics, involving almost 13K patients in 500 🏥 in 30 countries"-@DrTedros
"In June, we announced that we were discontinuing the hydroxychloroquine arm of the study, and in July we announced that we would no longer enrol patients to receive the combination of lopinavir and ritonavir"- @DrTedros#COVID19
People with cardiovascular disease or diabetes, as well as those with #hypertension and obesity, are at increased risk of severe disease and death from #COVID19.
Learn how to check your blood pressure today! bit.ly/2GV6rEf
Herd immunity is a concept used for vaccination, in which a population can be protected from a virus if a threshold of vaccination is reached. Vaccinated people are protected from getting the disease & passing it on, breaking any chains of transmission.
Herd immunity or population immunity is achieved by protecting people from a virus, not by exposing them to it. With herd immunity, the vast majority of a population are vaccinated, ⬇️ the overall amount of virus able to spread in the whole population.
In just six months, the world’s largest randomized control trial on #COVID19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.
Interim results from the Solidarity Therapeutics Trial, coordinated by WHO, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir & interferon regimens appeared to have little or no effect on mortality or reduction in hospital stays for #COVID19 patients.
The progress achieved by the Solidarity Therapeutics Trial shows that large international trials are possible, even during #COVID19 pandemic, & offer the promise of quickly & reliably answering critical public health questions concerning therapeutics.